Get started
UNITEDHEALTH GROUP INCUNITEDHEALTH GROUP INCUNITEDHEALTH GROUP INC

UNITEDHEALTH GROUP INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

UNH trade ideas

UNH Long Setup – Oversold Reversal PlayUnitedHealth ( NYSE:UNH ) is showing early signs of a potential bounce after a brutal selloff. 🔹 Price broke above the baseline (Ichimoku), first green candle close with bullish momentum 🔹 Williams %R showing oversold bounce from -80 levels 🔹 MACD turning positive on multiple timeframes 🔹 Clean risk/reward setup: ‣ Entry: $293 ‣ Target: $455 (55% upside) ‣ Stop: $249 (15% risk) ‣ R/R Ratio: 3.5+ This could be a high-reward reversal play if market strength continues. Watching closely for follow-through confirmation. #UNH #stocks #longsetup #tradingview #healthcare #swingtrade #technicalanalysis #chartsetup #Ichimoku
NYSE:UNHLong
by aaronkaltman
4
UNH: Why I Believe This Is a Dead Cat Bounce(Late posting)We’ve seen a quite the abounce in the market as of lately, but I believe it’s not a real recovery. To me, this looks like a classic dead cat bounce; a quick move up that happens during a downtrend before prices drop again. I’ll explain why I think this is the case, kind of a simple one. First of all, the grand picture in the economy still looks fairly negative, especially respecting the TRUMP TARIFF new. Inflation hasn’t fully gone away, interest rates are still high, and consumer confidence is weak. There’s no major change in the news or the fundamentals that would support a strong comeback. It feels like people are just hoping things will improve, but the facts don’t really support that yet. Second, the volume on this bounce has been low. In trading, volume tells you how strong a move is. If the price goes up but not many people are trading, it usually means there’s not much real buying happening. This bounce seems to be driven more by short sellers covering their positions, not by confident investors jumping in. Third, we’re hitting key resistance levels—areas where the price dropped before—and we’re starting to see signs of rejection again. These levels are often hard to break through unless the market has strong momentum, and right now it doesn’t look like that’s the case. Fourth, if you look at indicators like the RSI and MACD, they show that the price is already overbought. That means the recent move up may have gone too far, too fast. These kinds of readings usually lead to a pullback, especially when the bigger trend is still down. Finally, the overall structure of the chart hasn’t changed. We’re still making lower highs and lower lows, which is what a downtrend looks like. Just because we’ve had a few green candles doesn’t mean the trend has reversed. Until we see the market start building a base and making new highs with strong support, I don’t think this bounce will last. I n my opinion, this is one of those moments where people might get too excited too quickly. A lot of traders jump in thinking the bottom is in, only to get caught when the price turns back down. That’s why I’m staying cautious and watching for signs that the bounce is failing. I could be wrong, but right now, this feels more like a trap than a turning point.
NYSE:UNHShort
by ThePlotThickens
5
UNH watch $288-297: Double Golden zone a serious Long Term Buy?UNH keeps getting bad news but may have bottomed. Wave may have tested Double Golden fibs successfully. Looking for some consolidation then launch of recovery. $287.91-296.92 (Gold) is the key zone of interest. $382.05-384.18 (Red) is the first long term target. $251.94-255.83 (Green) is the MUST_HOLD bottom. . Previous Analysis that caught the top EXACTLY Follow and Boost to encourage more such PRECISE charts. ================================================== .
NYSE:UNH
by EuroMotif
4
UNH Under Pressure – Below EMA 200 with Heavy Selling VolumeUNH (UnitedHealth) is showing clear bearish signs: Price has dropped below the EMA 200, a key long-term support level Recent sessions show strong selling volume, indicating institutional exit Trend is downward, with no bullish confirmation yet ⚠️ I stay cautious here — waiting for volume shift or price reclaim above EMA before considering a reversal. Until then, the bearish momentum stays active. Not financial advice – just my technical view. #UNH #StockAnalysis #BearishTrend #VolumeAnalysis #EMA200 #TechnicalTrading #HealthcareStocks
NYSE:UNH
by abdeljalillariam
Generational Buy - Congratulations Well done to those that bought the dip on this below $300. I filled 80% of my position at $250 - the Point of Control according to the highest volume node. We had a capitulation in the top healthcare insurer. Absolute peak fear given the long list of events which culminated in the CEO leaving. His departure could have been the final flush out as holders capitulated. This presented a unique opportunity to get in on an undervalued stock trading at a P/E of 11.1. I’m a trader, so I won’t comment on the ethics of this company, it’s beyond the scope of my work. Technically I expect this relief rally to continue but in a corrective fashion with a potential resistance level looming. The 5th wave ending is normally followed by an abc correction, wave A has concluded, wave B is in play so I expect onward bullish recovery. For confluence, the weekly RSI had a complete reset hitting level of 30, the most oversold in many years. My indicator has flashed green (buy) so $250 could have been a generational low. None of this is financial advice, I got in at a good entry and I have a stop loss in place if this poops the bed again.
NYSE:UNHLong
by NoFOMO_
UnitedHealth (UNH) Share Price ReboundsUnitedHealth (UNH) Share Price Rebounds A month ago, in our analysis of the UNH chart, we: → highlighted that UnitedHealth shares had lost nearly 23% in value; → drew a descending channel and suggested that bearish pressure could continue, threatening the support level around $450, which had held since early 2022. Since then, UNH’s stock price decisively broke below that level (as marked by the arrow), falling to around $250 — its lowest point since spring 2020 — before staging a sharp rebound. This steep price movement was driven by a series of fundamental developments, including: → the resignation of the CEO and news of a Department of Justice investigation into potential Medicare fraud; → UnitedHealth withdrawing its earnings guidance for the coming year; → political debates over the Medicaid programme as part of the 2025 budget negotiations; → President Trump’s directive to cut prescription drug prices. Recent news that the new CEO and several top executives have bought tens of millions of dollars’ worth of UNH shares appears to have renewed investor confidence — the share price rose above the $300 mark yesterday. Technical Analysis of UNH Share Chart These latest developments justify an update to the descending channel configuration. Of particular note is the gradual decline with limited volatility — a sign that the price is moving along the channel's median line (highlighted on the chart). In this setup: → the bounce from the $250 level points to the lower boundary of the channel; → traders may consider a scenario where the current recovery pushes UnitedHealth stock towards the median, after which supply pressure may return and offset the recent dominance of demand. It’s also possible that the key psychological level of $300 could now act as support. This article represents the opinion of the Companies operating under the FXOpen brand only. It is not to be construed as an offer, solicitation, or recommendation with respect to products and services provided by the Companies operating under the FXOpen brand, nor is it to be considered financial advice.
NYSE:UNH
by FXOpen
Not All Hype = Opportunity | UnitedHealth $UNH Analysis Lately, I’ve been seeing a lot of chatter about buying NYSE:UNH — UnitedHealth Group — as if it’s the “big opportunity” after the drop… But let’s keep it real — the chart isn’t confirming that yet. 👀 Take a close look 👇 Price completely broke structure from previous highs around $630. The recent drop was aggressive, and there's no clean retest or setup forming yet. Unlike NASDAQ:MSTR (MicroStrategy), which gave us a structured pullback and liquidity sweep, NYSE:UNH still looks like it has more downside to go. ⚠️ I’m not rushing in because the news or a rumor says “buy now.” I’d rather wait for a clearer structure, a lower low, and a reaction from a real demand zone — just like the example I marked on MicroStrategy. This is a great reminder: Let price tell you when it's time — not social media hype. For now, NYSE:UNH goes on the watchlist, not the buy list. 📉🧠
NYSE:UNHShort
by MoNi_MoN
UNH | Catching the Fall Risky Play💊 Oversold Swing Play ⚠️ Risk Factor You're not trading a bounce—you’re stepping into a fire. Legal risk + uncertainty = extreme volatility. However, if markets stabilize, UNH could deliver a powerful mean-reversion move. UnitedHealth ( NYSE:UNH ) is trading in panic territory after: DOJ launched a criminal probe tied to Medicare Advantage billing Abrupt CEO resignation Suspended 2025 financial guidance, sparking investor selloff Still, the fundamentals aren’t dead. Q1 revenue is strong, and long-term value is on the table. 🎯 Trade Plan 🟢 Entry Zones 🔹 Zone 1: $275–$285 → Technical support + RSI oversold 🔹 Zone 2: $255 → 2021 breakout retest 🔹 Zone 3: $225 → Ultimate fear zone (deep capitulation possible) 💰 Profit Targets ✅ TP1: $300 – Psychological level & minor resistance ✅ TP2: $340 – Gap-fill area & 50-day MA ✅ TP3: $385+ – Long-term value zone if sentiment reverses 📌 Final Word UNH is no penny stock—it’s a $280B giant under siege. If you believe fear is overdone, this is a calculated shot at a rebound. Just keep your stops tight and your thesis tighter. 🚨 Disclaimer: This is not financial advice. Trading involves risk. Always DYOR and manage your exposure carefully.
NYSE:UNHLong
by Robert_V12
2
UNH: Short OTM puts expiring May 23UNH bounced from the $248.88 low and will probably not hit new low the following week. IV was relative high due to volatile stock price movement. Hence, setting up naked shorts on OTM puts. Max potential profits: $1,000+ premiums on May 23 Exit strategy: buy back gradually if UNH price crosses down $240 to secure positive results; otherwise, close all on May 23 Instrument Entry Date UNH 23MAY25 200P 2025-05-15 UNH 23MAY25 210P 2025-05-16 UNH 23MAY25 225P 2025-05-16 ========== STATS ========== Number of traded instruments YTD: 20 P/L YTD: $2K Win rate: 100%
NYSE:UNHShort
by SteadyGainsCA
1